[-] Show simple item record

dc.contributor.authorMcPherson, Vanessaeng
dc.contributor.authorLeach, Lauraeng
dc.date.issued2005eng
dc.description.abstractAbrupt discontinuation of the offending analgesic(s), and treating rebound headaches with dihydroergotamine (DHE) as needed, results in significant improvement for most patients (strength of recommendation [SOR]: C; based on case series). Amitriptyline does not affect the frequency or severity of rebound headaches, but it may improve quality of life (SOR: B, low-powered randomized controlled trial). Prednisone or naratriptan (Amerge) lessen acute withdrawal symptoms from analgesics and reduce the need for rescue medications during the first 6 days of treatment; however, they do not affect headache frequency or severity (SOR: B, low-quality randomized controlled trial).eng
dc.identifier.urihttp://hdl.handle.net/10355/3335eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2005 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 54, no. 03 (March 2005): 277-278.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectpain reliefeng
dc.subjectmigraineeng
dc.subjectwithdrawal symptomseng
dc.subject.lcshAnalgesicseng
dc.subject.lcshDrug withdrawal symptomseng
dc.subject.lcshHeadacheeng
dc.titleWhat is the best treatment for analgesic rebound headaches?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record